neobookRx
GuidelinesOther guideline

References

Crichton A. An inquiry into the nature and origin of mental derangement: Comprehending a concise system of the physiology and pathology of the human mind and a history of the passions and their effects. London: T. Cadell and W. Davies; 1798. Goldstein S. Managing attention and learning disorders in late adolescence and adulthood. New York, NY: Wiley; 1997. Thomas R, Sanders S, Doust J, Beller E,

  1. Crichton A. An inquiry into the nature and origin of mental derangement: Comprehending a concise system of the physiology and pathology of the human mind and a history of the passions and their effects. London: T. Cadell and W. Davies; 1798.
  2. Goldstein S. Managing attention and learning disorders in late adolescence and adulthood. New York, NY: Wiley; 1997.
  3. Thomas R, Sanders S, Doust J, Beller E, Glasziou P. Prevalence of attention-deficit/ hyperactivity disorder: A systematic review and meta-analysis. Pediatrics. 2015;135(4):e994–1001. https://doi.org/10.1542/peds.2014-3482
  4. Salari N, Ghasemi H, Abdoli N, et al. The global prevalence of ADHD in children and adolescents: A systematic review and meta-analysis. Ital J Pediatr. 2023;49(1):48–60. https://doi.org/10.1186/s13052-023-01456-1
  5. Simon V, Czobor P, Bálint S, et al. Prevalence and correlates of adult attentiondeficit hyperactivity disorder: Meta-analysis. Br J Psychiatry. 2009;194(3): 204–211. https://doi.org/10.1192/bjp.bp.107.048827
  6. Polanczyk G, De Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: A systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–948. https://doi.org/10.1176/ajp.2007.164.6.942
  7. Meyer A, Eilertsen D-E, Sundet JM, Tshifularo J, Sagvolden T. Cross-cultural similarities in ADHD-like behaviour amongst South African primary school children. S Afr J Psychol. 2004;34(1):122–138. https://doi.org/10.1177/008124630403400108
  8. Schoeman R, Enright J, James A, Vermeulen C, De Beer N. Removing mental health barriers to education: A community project. S Afr J Psychiat. 2018;24:a1293. https://doi.org/10.4102/sajpsychiatry.v24i0.1293
  9. Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attentiondeficit hyperactivity disorder. Acta Paediatr. 2007;96(9):1269–1274. https://doi. org/10.1111/j.1651-2227.2007.00430.x
  10. Cortese S. The neurobiology and genetics of attention-deficit/hyperactivity disorder (ADHD): What every clinician should know. Eur J Paediatr Neurol. 2012;16(5):422–433. https://doi.org/10.1016/j.ejpn.2012.01.009
  11. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789–818. https://doi.org/10.1016/j. neubiorev.2021.01.022
  12. Schoeman R, Liebenberg R. The South African Society of Psychiatrists/Psychiatry Management Group management guidelines for adult attention-deficit/ hyperactivity disorder. S Afr J Psychiat. 2017;23:a1060. https://doi.org/10.4102/ sajpsychiatry.v23i0.1060
  13. Radmanovic MB, Burgic S-S. Comorbidity in children and adolescents with ADHD. In: Kupersack HG, editor. ADHD: From etiology to comorbidity. London: IntechOpen; 2021; p. 1–20.
  14. American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing, Inc.; c2013.
  15. Mulraney M, Arrondo G, Musullulu H, et al. Systematic review and meta-analysis: Screening tools for attention-deficit/hyperactivity disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry. 2022;61(8):982–996. https:// doi.org/10.1016/j.jaac.2021.11.031
  16. Conners CK, Sitarenios G, Parker JD, Epstein JN. The revised Conners’ Parent Rating Scale (CPRS-R): Factor structure, reliability, and criterion validity. J Abnorm Child Psychol. 1998;26(4):257–268. https://doi.org/10.1023/A:1022602400621
  17. Swanson JM, Schuck S, Porter MM, et al. Categorical and dimensional definitions and evaluations of symptoms of ADHD: History of the SNAP and the SWAN rating scales. Int J Educ Psychol Assess. 2012;10(1):51–70.
  18. Wolraich ML, Lambert W, Doffing MA, Bickman L, Simmons T, Worley K. Psychometric properties of the Vanderbilt ADHD diagnostic parent rating scale in a referred population. J Pediatr Psychol. 2003;28(8):559–568. https://doi. org/10.1093/jpepsy/jsg046
  19. Parker A, Corkum P. ADHD diagnosis: As simple as administering a questionnaire or a complex diagnostic process? J Atten Disord. 2016;20(6):478–486. https://doi. org/10.1177/1087054713495736
  20. Copeland E. Copeland symptom checklist for attention deficit disorders. Atlanta, GA: Southeastern Psychological Institute; 1987.
  21. Peterson BS, Trampush J, Brown M, et al. Tools for the diagnosis of ADHD in children and adolescents: A systematic review. Pediatrics. 2024;153(4):e202406585. https://doi.org/10.1542/peds.2024-065854
  22. Hall CL, Guo B, Valentine AZ, et al. The validity of the SNAP-IV in children displaying ADHD symptoms. Assessment. 2020;27(6):1258–1271. https://doi.org/10.1177/ 1073191119842255
  23. Khambule NN. Investigating the psychometric properties of the VanderbiltAttention-Deficit-Hyperactivity-Disorder diagnostic rating scale (VADRS) within the South African context [master’s thesis]. Pietermaritzburg: University of KwaZulu-Natal; 2021.
  24. National Institute for Health and Clinical Excellence. Attention deficit hyperactivity disorder: Diagnosis and management [homepage on the Internet]. NICE guideline [NG87]. c2019 [updated 2019 Sept 13; cited 2024 Jun 06]. Available from: https:// www.nice.org.uk/guidance/ng87
  25. Canadian ADHD Resource Alliance. Canadian ADHD practice guidelines. 4.1 ed. Toronto, ON: CADDRA; 2020.
  26. Burkholder DB, Britton JW, Rajasekaran V, et al. Routine vs extended outpatient EEG for the detection of interictal epileptiform discharges. Neurology. 2016;86(16):1524–1530. https://doi.org/10.1212/WNL.0000000000002592
  27. Lenartowicz A, Loo SK. Use of EEG to diagnose ADHD. Curr Psychiatry Rep. 2014;16(11):498. https://doi.org/10.1007/s11920-014-0498-0
  28. Slater J, Joober R, Koborsy BL, Mitchell S, Sahlas E, Palmer C. Can electroencephalography (EEG) identify ADHD subtypes? A systematic review. Neurosci Biobehav Rev. 2022;139:104752. https://doi.org/10.1016/j.neubiorev.2022.104752
  29. Leark RA, Greenberg LM, Kindschi CL. T.O.V.A. professional manual. Test of variables of attention continuous performance test. Los Alamitos, CA: The TOVA Company; 2007.
  30. Berger I, Goldzweig G. Objective measures of attention-deficit/hyperactivity disorder: A pilot study. Isr Med Assoc J. 2010;12(9):531–535.
  31. Emser TS, Johnston BA, Steele JD, Kooij S, Thorell L, Christiansen H. Assessing ADHD symptoms in children and adults: Evaluating the role of objective measures. Behav Brain Funct. 2018;14(1):11. https://doi.org/10.1186/s12993-018-0143-x
  32. Jensen PS, Hinshaw SP, Kraemer HC, et al. ADHD comorbidity findings from the MTA study: Comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40(2):147–158. https://doi.org/10.1097/00004583-200102000-00009
  33. Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: Antisocial activities and drug use. J Child Psychol Psychiatry. 2004;45(2):195–211. https://doi.org/10.1111/j.1469-7610.2004.00214.x
  34. Duffy A. The nature of the association between childhood ADHD and the development of bipolar disorder: A review of prospective high-risk studies. Am J Psychiatry. 2012;169(12):1247–1255. https://doi.org/10.1176/appi.ajp.2012.11111725
  35. Youngstrom EA, Arnold LE, Frazier TW. Bipolar and ADHD comorbidity: Both artifact and outgrowth of shared mechanisms. Clin Psychol Sci Pract. 2010;17(4):350–359. https://doi.org/10.1111/j.1468-2850.2010.01226.x
  36. Biederman J, Mick E, Faraone SV. Depression in attention deficit hyperactivity disorder (ADHD) children: ‘True’ depression or demoralization? J Affect Disord. 1998;47(1–3):113–122. https://doi.org/10.1016/S0165-0327(97)00127-4
  37. Arnold LE, Demeter C, Mount K, et al. Pediatric bipolar spectrum disorder and ADHD: Comparison and comorbidity in the LAMS clinical sample. Bipolar Disord. 2011;13(5–6):509–521. https://doi.org/10.1111/j.1399-5618.2011.00948.x
  38. Roessner V, Becker A, Banaschewski T, Freeman RD, Rothenberger A, Tourette Syndrome International Database Consortium. Developmental psychopathology of children and adolescents with Tourette syndrome – Impact of ADHD. Eur Child Adolesc Psychiatry. 2007;16(Suppl. 1):24–35. https://doi.org/10.1007/s00787-007-1004-6
  39. Coffey BJ, Rapoport J. Obsessive-compulsive disorder and Tourette’s disorder: Where are we now? J Child Adolesc Psychopharmacol. 2010;20(4):235. https:// doi.org/10.1089/cap.2010.2041
  40. Leitner Y. The co-occurrence of autism and attention deficit hyperactivity disorder in children – What do we know? Front Hum Neurosci. 2014;8:268. https://doi. org/10.3389/fnhum.2014.00268
  41. Stevens T. The comorbidity of ADHD in children diagnosed with autism spectrum disorder. Res Autism Spectr Disord. 2016;31:11–18. https://doi.org/10.1016/j. rasd.2016.07.003
  42. Antshel K, Zhang-James Y, Wagner KE, Ledesma A, Faraone SV. An update on the comorbidity of ADHD and ASD: A focus on clinical management. Expert Rev Neurother. 2016;6(3):279–293. https://doi.org/10.1586/14737175.2016.1146591
  43. Sadeh A, Pergamin L, Bar-Haim Y. Sleep in children with attention-deficit hyperactivity disorder: A meta-analysis of polysomnographic studies. Sleep Med Rev. 2006;10(6):381–398. https://doi.org/10.1016/j.smrv.2006.03.004
  44. Reichow B, Volkmar FR, Bloch MH. Systematic review and meta-analysis of pharmacological treatment of the symptoms of ADHD in children with pervasive developmental disorders. J Autism Dev Disord. 2013;43(10):2435–2441. https:// doi.org/10.1007/s10803-013-1793-z
  45. DuPaul GJ, Gormley MJ, Laracy SD. Comorbidity of LD and ADHD: Implications of DSM-5 for assessment and treatment. J Learn Disabil. 2013;46(1):43–51. https:// doi.org/10.1177/0022219412464351
  46. Coogan AN, Baird AL, Popa-Wagner A, Thome J. Circadian rhythms and attention deficit hyperactivity disorder: The what, the when and the why. Prog Neuropsychopharmacol Biol Psychiatry. 2016;3(67):74–81. https://doi. org/10.1016/j.pnpbp.2016.01.006
  47. Galland BC, Tripp EG, Taylor BJ. The sleep of children with attention deficit hyperactivity disorder on and off methylphenidate: A matched case-control study. J Sleep Res. 2010;19(2):366–373. https://doi.org/10.1111/j.1365- 2869.2009.00795.x
  48. Cortese S, Brown TE, Corkum P, et al. Assessment and management of sleep problems in youths with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2013;52(8):784–796. https://doi.org/10.1016/j.jaac.2013.06.001
  49. Masi G, Fantozzi P, Villafranca A, et al. Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment. Neuropsychiatr Dis Treat. 2019;15:663–667. https://doi.org/10.2147/ NDT.S193891
  50. Lange S, Shield K, Rehm J, Anagnostou E, Popova S. Fetal alcohol spectrum disorder: Neurodevelopmentally and behaviorally indistinguishable from other neurodevelopmental disorders. BMC Psychiatry. 2019;19(1):322. https://doi. org/10.1186/s12888-019-2289-y
  51. Ilie G, Vingilis ER, Mann RE, et al. The association between traumatic brain injury and ADHD in a Canadian adult sample. J Psychiatr Res. 2015;69:174–179. https:// doi.org/10.1016/j.jpsychires.2015.08.004
  52. Ettinger AB, Ottman R, Lipton RB, Cramer JA, Fanning KM, Reed ML. Attentiondeficit/hyperactivity disorder symptoms in adults with self-reported epilepsy: Results from a national epidemiologic survey of epilepsy. Epilepsia. 2015;56(2):218–224. https://doi.org/10.1111/epi.12897
  53. Wang S, Yao B, Zhang H, et al. Comorbidity of epilepsy and attention-deficit/ hyperactivity disorder: A systematic review and meta-analysis. J Neurol. 2023;270(9):4201–4213. https://doi.org/10.1007/s00415-023-11794-z
  54. Fan HC, Chiang KL, Chang KH, Chen CM, Tsai JD. Epilepsy and attention deficit hyperactivity disorder: Connection, chance, and challenges. Int J Mol Sci. 2023;24(6):5270. https://doi.org/10.3390/ijms24065270
  55. Ono KE, Bearden DJ, Lee SM, et al. Interventions for ADHD in children & adolescents with epilepsy: A review and decision tree to guide clinicians. Epilepsy Behav. 2022;135:108872. https://doi.org/10.1016/j.yebeh.2022.108872
  56. Villa FM, Crippa A, Rosi E, Nobile M, Brambilla P, Delvecchio G. ADHD and eating disorders in childhood and adolescence: An updated minireview. J Affect Disord. 2023;321:265–271. https://doi.org/10.1016/j.jad.2022.10.016
  57. Biederman J, Ball SW, Monuteaux MC, Surman CB, Johnson JL, Zeitlin S. Are girls with ADHD at risk for eating disorders? Results from a controlled, five-year prospective study. J Dev Behav Pediatr. 2007;28(4):302–307. https://doi. org/10.1097/DBP.0b013e3180327917
  58. Cortese S, Moreira-Maia CR, St Fleur D, Morcillo-Peñalver C, Rohde LA, Faraone SV. Association between ADHD and obesity: A systematic review and metaanalysis. Am J Psychiatry. 2016;173(1):34–43. https://doi.org/10.1176/appi. ajp.2015.15020266
  59. Ravi P, Khan S. Attention deficit hyperactivity disorder: Association with obesity and eating disorders. Cureus. 2020;12(12):e12085. https://doi.org/10.7759/ cureus.12085
  60. Wentz E, Björk A, Dahlgren J. Is there an overlap between eating disorders and neurodevelopmental disorders in children with obesity? Nutrients. 2019;11(10):2496. https://doi.org/10.3390/nu11102496
  61. Niemczyk J, Equit M, Hoffmann L, Von Gontard A. Incontinence in children with treated attention-deficit/hyperactivity disorder. J Pediatr Urol. 2015;11(3):141. e1–e6. https://doi.org/10.1016/j.jpurol.2015.02.009
  62. Thorell LB, Burén J, Ström Wiman J, Sandberg D, Nutley SB. Longitudinal associations between digital media use and ADHD symptoms in children and adolescents: A systematic literature review. Eur Child Adolesc Psychiatry. 2022;33(8):2503–2526. https://doi.org/10.1007/s00787-022-02130-3
  63. Berloffa S, Salvati A, D’Acunto G, et al. Internet gaming disorder in children and adolescents with attention deficit hyperactivity disorder. Children (Basel). 2022;9(3):428. https://doi.org/10.3390/children9030428
  64. ADHD Guideline Development Group. Australian evidence-based clinical practice guideline for attention deficit hyperactivity. Melbourne: Australian ADHD Professionals Association; 2022.
  65. Gnanavel S, Sharma P, Kaushal P, Hussain S. Attention deficit hyperactivity disorder and comorbidity: A review of literature. World J Clin Cases. 2019;7(17): 2420–2426. https://doi.org/10.12998/wjcc.v7.i17.2420
  66. Tung I, Li JJ, Meza JI, et al. Patterns of comorbidity among girls with ADHD: A metaanalysis. Pediatrics. 2016;138(4):e20160430. https://doi.org/10.1542/peds.2016-0430
  67. Botha J, Schoeman R. Attention deficit hyperactivity disorder: Insights into underfunding in the private healthcare sector in South Africa. S Afr J Psychiatr. 2023;29:2050. https://doi.org/10.4102/sajpsychiatry.v29i0.2050
  68. Buitelaar J, Bolte S, Brandeis D, et al. Toward precision medicine in ADHD. Front Behav Neurosci. 2022;16:900981. https://doi.org/10.3389/fnbeh.2022.900981
  69. Dalsgaard S, Østergaard SD, Leckman JF, Mortensen PB, Pedersen MG. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: A nationwide cohort study. Lancet. 2015;385(9983):2190–2196. https://doi. org/10.1016/S0140-6736(14)61684-6
  70. Wu EQ, Hodgkins P, Ben-Hamadi R, et al. Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: A systematic literature review. CNS Drugs. 2012;26(7):581–600. https://doi.org/10.2165/11633900-000000000-00000
  71. Heal DJ, Smith SL, Findling RL. ADHD: Current and future therapeutics. Curr Top Behav Neurosci. 2012;9:361–390. https://doi.org/10.1007/7854_2011_125
  72. Faraone SV, Biederman J, Mick E. The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychol Med. 2006;36(2):159–165. https://doi.org/10.1017/S003329170500471X
  73. Arnold LE. Methylphenidate vs. amphetamine: Comparative review. J Atten Disord. 2000;3(4):200–211. https://doi.org/10.1177/108705470000300403
  74. Ramtvedt BE, Røinås E, Aabech HS, Sundet KS. Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials. J Child Adolesc Psychopharmacol. 2013;23(9):597–604. https://doi.org/10.1089/cap.2012.0085
  75. Cascade E, Kalali AH, Weisler RH. Short-acting versus long-acting medications for the treatment of ADHD. Psychiatry (Edgmont). 2008;5(8):24–27.
  76. Wilens T, Pelham W, Stein M, et al. ADHD treatment with once-daily OROS methylphenidate: Interim 12-month results from a long-term open-label study. J Am Acad Child Adolesc Psychiatry. 2003;42(4):424–433. https://doi. org/10.1097/01.CHI.0000046814.95464.7D
  77. Faraone SV, Biederman J, Spencer TJ, Aleardi M. Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed. 2006;8(4):4.
  78. Mechler K, Banaschewski T, Hohmann S, Häge A. Evidence-based pharmacological treatment options for ADHD in children and adolescents. Pharmacol Ther. 2022;230:107940. https://doi.org/10.1016/j.pharmthera.2021.107940
  79. Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A. Nonstimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry. 2004;13(1):102–116. https://doi.org/10.1007/s00787-004-1010-x
  80. Wilens TE, Upadhaya HP. Impact of substance use disorder on ADHD and its treatment. J Clin Psychiatry. 2007;68(8):E20. https://doi.org/10.4088/JCP.0807e20
  81. León-Barriera R, Ortegon RS, Chaplin MM, Modesto-Lowe V. Treating ADHD and comorbid anxiety in children: A guide for clinical practice. Clin Pediatr (Phila). 2023;62(1):39–46. https://doi.org/10.1177/00099228221111246
  82. Breda V, Rohde LA, Menezes AMB, et al. The neurodevelopmental nature of attention-deficit hyperactivity disorder in adults. Br J Psychiatry. 2021;218(1): 43–50. https://doi.org/10.1192/bjp.2020.200
  83. Van Vyve AL, Dierckx B, Lim CG, et al. Pharmacotherapy for ADHD in children and adolescents: A summary and overview of different European guidelines. Eur J Pediatr. 2024;183(3):1047–1056. https://doi.org/10.1007/s00431-023-05370-w
  84. Faraone SV, Bonvicini C, Scassellati C. Biomarkers in the diagnosis of ADHD – Promising directions. Curr Psychiatry Rep. 2014;16(11):497. https://doi. org/10.1007/s11920-014-0497-1
  85. Wang L-J, Yang C-Y, Chou WJ, et al. Gut microbiota and dietary patterns in children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2020;29(3):287–297. https://doi.org/10.1007/s00787-019-01352-2
  86. Sonuga-Barke EJS, Brandeis D, Cortese S, et al. Nonpharmacological interventions for ADHD: Systematic review and meta-analyses of randomized controlled trials of dietary and psychological treatments. Am J Psychiatry. 2013;170(3):275–289. https://doi.org/10.1176/appi.ajp.2012.12070991
  87. Sibley MH, Bruton AM, Zhao X, et al. Non-pharmacological interventions for attention-deficit hyperactivity disorder in children and adolescents. Lancet Child Adolesc Health. 2023;7(6):415–428. https://doi.org/10.1016/S2352- 4642(22)00381-9
  88. Groenman AP, Hornstra R, Hoekstra PJ, et al. An individual participant data metaanalysis: Behavioral treatments for children and adolescents with attentiondeficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2022;61(2): 144–158. https://doi.org/10.1016/j.jaac.2021.02.024
  89. Evans SW, Owens JS, Wymbs BT, Ray AR. Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder. J Clin Child Adolesc Psychol. 2018;47(2):157–198. https://doi.org/10.1080/15374416.2 017.1390757
  90. Fabiano GA, Pelham WE, Coles EK, Gnagy EM, Chronis-Tuscano A, O’Connor BC. A meta-analysis of behavioral treatments for attention-deficit/hyperactivity disorder. Clin Psychol Rev. 2009;29(2):129–140. https://doi.org/10.1016/j. cpr.2008.11.001
  91. Chin LP, Wing N, Jan YH, Hung CVC, Chung LK. A meta-analysis of behavioral parent training for children with attention deficit hyperactivity disorder. Res Dev Disabil. 2012;33(6):2040–2049. https://doi.org/10.1016/j.ridd.2012.05.011
  92. Kretschmer CR, Göz Tebrizcik B, Dommett EJ. Mindfulness interventions for attention deficit hyperactivity disorder: A systematic review and meta-analysis. Psychiatry Int. 2022;3(4):363–399. https://doi.org/10.3390/psychiatryint3040031
  93. Cassone AR. Mindfulness training as an adjunct to evidence-based treatment for ADHD within families. J Atten Disord. 2015;19(2):147–157. https://doi. org/10.1177/1087054713488438
  94. Smalley SL, Loo SK, Hale TS, et al. Mindfulness and attention deficit hyperactivity disorder. J Clin Psychol. 2009;65(10):1087–1098. https://doi.org/10.1002/jclp.20618
  95. Westwood SJ, Conti AA, Tang W, Xue S, Cortese S, Rubia K. Clinical and cognitive effects of external trigeminal nerve stimulation (eTNS) in neurological and psychiatric disorders: A systematic review and meta-analysis. Mol Psychiatry. 2023;28(10):4025–4043. https://doi.org/10.1038/s41380-023-02227-4
  96. Rutledge KJ, Van Den Bos W, McClure SM, Schweitzer JB. Training cognition in ADHD: Current findings, borrowed concepts, and future directions. Neurotherapeutics. 2012;9(3):542–558. https://doi.org/10.1007/s13311-012- 0134-9
  97. Cortese S, Ferrin M, Brandeis D, et al. Cognitive training for attention-deficit/ hyperactivity disorder: Meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials. J Am Acad Child Adolesc Psychiatry. 2015;54(3):164–174. https://doi.org/10.1016/j.jaac.2014.12.010
  98. Sonuga-Barke E, Brandeis D, Holtmann M, Cortese S. Computer-based cognitive training for ADHD: A review of current evidence. Child Adolesc Clin N Am. 2014;23(4):807–824. https://doi.org/10.1016/j.chc.2014.05.009
  99. Holtmann M, Sonuga-Barke E, Cortese S, Brandeis D. Neurofeedback for ADHD: A review of current evidence. Child Adolesc Clin N Am. 2014;23(4):789–806. https://doi.org/10.1016/j.chc.2014.05.006
  100. Rubia K. Neurotherapeutics for ADHD: Do they work? Psych J. 2022;11(3):419–427. https://doi.org/10.1002/pchj.544
  101. Rubio B, Boes AD, Laganiere S, Rotenberg A, Jeurissen D, Pascual-Leone A. Noninvasive brain stimulation in pediatric ADHD: A review. J Child Neurol. 2016;31(6):784–796. https://doi.org/10.1177/0883073815615672
  102. Sun W, Yu M, Zhou X. Effects of physical exercise on attention deficit and other major symptoms in children with ADHD: A meta-analysis. Psychiatry Res. 2022;311:114509. https://doi.org/10.1016/j.psychres.2022.114509
  103. Zang Y. Impact of physical exercise on children with attention deficit hyperactivity disorders: Evidence through a meta-analysis. Medicine (Baltimore). 2019;98(46):e17980. https://doi.org/10.1097/MD.0000000000017980
  104. Mattes JA. The Feingold diet: A current reappraisal. J Learn Disabil. 1983;16(6):319–323. https://doi.org/10.1177/002221948301600602
  105. Lange KW, Reissmann A, Nakamura Y, Lange KM. Food intolerance and oligoantigenic diet in children with attention-deficit hyperactivity disorder. Food Sci Hum Wellness. 2024;13(4):1729–1738. https://doi.org/10.26599/ FSHW.2022.9250146
  106. Siervo M, Lara J, Chowdhury S, Ashor A, Oggioni C, Mathers JC. Effects of the dietary approach to stop hypertension (DASH) diet on cardiovascular risk factors: A systematic review and meta-analysis. Br J Nutr. 2015;113(1):1–15. https://doi.org/10.1017/S0007114514003341
  107. Lange KW. Micronutrients and diets in the treatment of attention-deficit/ hyperactivity disorder: Chances and pitfalls. Front Psychiatry. 2020;11:102. https://doi.org/10.3389/fpsyt.2020.00102
  108. Khoshbakht Y, Moghtaderi F, Bidaki R, Hosseinzadeh M, Salehi-Abargouei A. The effect of dietary approaches to stop hypertension (DASH) diet on attentiondeficit hyperactivity disorder (ADHD) symptoms: A randomized controlled clinical trial. Eur J Nutr. 2021;60(7):3647–3658. https://doi.org/10.1007/ s00394-021-02527-x
  109. National Center for Complementary and Integrative Health. Complementary, alternative, or integrative health: What’s in a name? [homepage on the Internet]. 2021 [cited 2024 Mar 1]. Available from: https://www.nccih.nih.gov/health/ complementary-alternative-or-integrative-health-whats-in-a-name
  110. Bloch MH, Qawasmi A. Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: Systematic review and meta-analysis. J Am Acad Child Adolesc Psychiatry. 2011;50(10):991–1000. https://doi.org/10.1016/j.jaac.2011.06.008
  111. Chang JC, Su KP, Mondelli V, et al. Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: A systematic review and metaanalysis of clinical trials and biological studies. Neuropsychopharmacol. 2018;43(3):534–545. https://doi.org/10.1038/npp.2017.160
  112. Hawkey E, Nigg JT. Omega-3 fatty acid and ADHD: Blood level analysis and meta-analytic extension of supplementation trials. Clin Psychol Rev. 2014;34(6):496–505. https://doi.org/10.1016/j.cpr.2014.05.005
  113. Cooper RE, Tye C, Kuntsi J, Vassos E, Asherson P. The effect of omega-3 polyunsaturated fatty acid supplementation on emotional dysregulation, oppositional behaviour and conduct problems in ADHD: A systematic review and meta-analysis. J Affect Disord. 2016;190:474–482. https://doi.org/10.1016/j. jad.2015.09.053
  114. Barragán E, Breuer D, Dopfner M. Efficacy and safety of omega-3/6 fatty acids, methylphenidate, and a combined treatment in children with ADHD. J Atten Disord. 2014;31(6):1–9.
  115. Rucklidge JJ, Frampton CM, Gorman B, Boggis A. Vitamin-mineral treatment of attention-deficit hyperactivity disorder in adults: Double-blind randomised placebo-controlled trial. Br J Psychiatry. 2014;204:306–315. https://doi. org/10.1192/bjp.bp.113.132126
  116. Sarris J, Kean J, Schweitzer I, Lake J. Complementary medicines (herbal and nutritional products) in the treatment of attention deficit hyperactivity disorder: A systematic review of the evidence. Complement Ther Med. 2011;19(4): 216–227. https://doi.org/10.1016/j.ctim.2011.06.007
  117. Reale L, Costantino MA, Sequi M, Bonati M. A regional ADHD center-based network project for the diagnosis and treatment of children and adolescents with ADHD. J Atten Disord. 2018;22(6):601–608. https://doi.org/10.1177/ 1087054714560823

Click here for the pdf.

Belsham B, Kelly L, Schoeman R_The SASOP/PsychMg child and adolescent attention-deficit/hyperactivity disorder guidelines_South African Journal of Psychiatry; 25 February 2025

Drugs mentioned

NeoHealth® ID 19722 · updated 2/28/2025